BACKGROUND AND PURPOSE: In the brain of HIV-infected patients, proton MR spectroscopic studies are typically used to examine small volumes of tissue with single-voxel methods. Since brain disease is diffuse in patients with HIV, such studies preclude assessment of the true extent of the metabolic burden. To assess this extent, the relationship between global neuronal integrity, reflected by the whole-brain N-acetylaspartate (WBNAA) concentration, was correlated with neuropsychological function and the AIDS dementia complex (ADC) stage score. METHODS: WBNAA levels were compared between 15 HIV-infected patients (seven symptomatic, eight asymptomatic) and 13 age- and sex-matched healthy subjects. The patients' WBNAA level was correlated with cognitive performance, as measured with a battery of eight tests (NPZ-8), including the ADC stage score and four total-memory, mood, motor, and processing speed subtests. RESULTS: WBNAA levels were significantly different between patients and healthy subjects (mean +/- sigma, 11.82 +/- 1.40 and 12.91 +/- 1.03 mmol/L, respectively; P =.032) after we adjusted for age and sex effects. Intermediate negative correlations were found between the WBNAA level, the processing speed subtest score (r = -0.50, P =.03), and the ADC stage score (r = -0.44, P =.05). CONCLUSION: The WBNAA concentration complements brain atrophy data with information about the quality of the remaining neuronal and axonal tissue in patients with HIV infection. In HIV-infected patients, its correlation with processing speed and the ADC score indicates that the latter reflects pathologic deficits, which are extensive throughout the brain.
BACKGROUND AND PURPOSE: In the brain of HIV-infectedpatients, proton MR spectroscopic studies are typically used to examine small volumes of tissue with single-voxel methods. Since brain disease is diffuse in patients with HIV, such studies preclude assessment of the true extent of the metabolic burden. To assess this extent, the relationship between global neuronal integrity, reflected by the whole-brain N-acetylaspartate (WBNAA) concentration, was correlated with neuropsychological function and the AIDS dementia complex (ADC) stage score. METHODS: WBNAA levels were compared between 15 HIV-infectedpatients (seven symptomatic, eight asymptomatic) and 13 age- and sex-matched healthy subjects. The patients' WBNAA level was correlated with cognitive performance, as measured with a battery of eight tests (NPZ-8), including the ADC stage score and four total-memory, mood, motor, and processing speed subtests. RESULTS: WBNAA levels were significantly different between patients and healthy subjects (mean +/- sigma, 11.82 +/- 1.40 and 12.91 +/- 1.03 mmol/L, respectively; P =.032) after we adjusted for age and sex effects. Intermediate negative correlations were found between the WBNAA level, the processing speed subtest score (r = -0.50, P =.03), and the ADC stage score (r = -0.44, P =.05). CONCLUSION: The WBNAA concentration complements brain atrophy data with information about the quality of the remaining neuronal and axonal tissue in patients with HIV infection. In HIV-infectedpatients, its correlation with processing speed and the ADC score indicates that the latter reflects pathologic deficits, which are extensive throughout the brain.
Authors: H E Möller; P Vermathen; M G Lentschig; G Schuierer; S Schwarz; D Wiedermann; S Evers; I W Husstedt Journal: J Magn Reson Imaging Date: 1999-01 Impact factor: 4.813
Authors: F Gray; F Scaravilli; I Everall; F Chretien; S An; D Boche; H Adle-Biassette; L Wingertsmann; M Durigon; B Hurtrel; F Chiodi; J Bell; P Lantos Journal: Brain Pathol Date: 1996-01 Impact factor: 6.508
Authors: Sohil H Patel; Dennis L Kolson; Guila Glosser; Isabel Matozzo; Yulin Ge; James S Babb; Lois J Mannon; Robert I Grossman Journal: AJNR Am J Neuroradiol Date: 2002-04 Impact factor: 3.825
Authors: J R McConnell; S Swindells; C S Ong; W H Gmeiner; W K Chu; D K Brown; H E Gendelman Journal: AIDS Res Hum Retroviruses Date: 1994-08 Impact factor: 2.205
Authors: Ronald A Cohen; Jaroslaw Harezlak; Giovanni Schifitto; George Hana; Uraina Clark; Assawin Gongvatana; Robert Paul; Michael Taylor; Paul Thompson; Jeffery Alger; Mark Brown; Jianhui Zhong; Thomas Campbell; Elyse Singer; Eric Daar; Deborah McMahon; Yuen Tso; Constantin T Yiannoutsos; Bradford Navia Journal: J Neurovirol Date: 2010-02 Impact factor: 2.643
Authors: Timothy C Durazzo; Johannes C Rothlind; Valerie A Cardenas; Colin Studholme; Michael W Weiner; Dieter J Meyerhoff Journal: Alcohol Date: 2007-10-17 Impact factor: 2.405
Authors: Ronald A Cohen; Jaroslaw Harezlak; Assawin Gongvatana; Steven Buchthal; Giovanni Schifitto; Uraina Clark; Robert Paul; Michael Taylor; Paul Thompson; David Tate; Jeffery Alger; Mark Brown; Jianhui Zhong; Thomas Campbell; Elyse Singer; Eric Daar; Deborah McMahon; Yuen Tso; Constantin T Yiannoutsos; Bradford Navia Journal: J Neurovirol Date: 2010-10-20 Impact factor: 2.643
Authors: Brian J Soher; William E Wu; Assaf Tal; Pippa Storey; Ke Zhang; James S Babb; Ivan I Kirov; Yvonne W Lui; Oded Gonen Journal: NMR Biomed Date: 2014-09-05 Impact factor: 4.044
Authors: Xue Hua; Christina P Boyle; Jaroslaw Harezlak; David F Tate; Constantin T Yiannoutsos; Ron Cohen; Giovanni Schifitto; Assawin Gongvatana; Jianhui Zhong; Tong Zhu; Michael J Taylor; Thomas B Campbell; Eric S Daar; Jeffry R Alger; Elyse Singer; Steve Buchthal; Arthur W Toga; Bradford Navia; Paul M Thompson Journal: Neuroimage Clin Date: 2013-08-03 Impact factor: 4.881